Vertex sinks on reports of deaths of patients taking cystic fibrosis drug
Thirty patients have died after taking a Vertex Pharmaceuticals treatment for cystic fibrosis, according to a government database, news that sent the company’s share price down as much as 4% on Wednesday morning.
The deaths, reported to the Food and Drug Administration’s database of side effects, relate to patients who took Symdeko, a Vertex medicine approved last year. Reports to the database are commonly submitted by health care professionals and often contain incomplete information about how patients died and what other medicines they were taking. It’s also unclear whether any of the deaths are directly related to Symdeko.
Read Original Article: Vertex sinks on reports of deaths of patients taking cystic fibrosis drug »
